Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

Details for Australian Patent Application No. 2005270918 (hide)

Owner Universita Di Genova Innate Pharma S.A.

Inventors Bottino, Christina; Moretta, Alessandro; Moretta, Lorenzo; Castriconi, Roberta

Agent Davies Collison Cave

Pub. Number AU-B-2005270918

PCT Pub. Number WO2006/016276

Priority 60/598,727 03.08.04 US

Filing date 2 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 3 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/016276 Priority application(s): WO2006/016276

3 March 2011 Application Accepted

  Published as AU-B-2005270918

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270921-Filter device for fluids and method for filtering fluids

2005270917-Gastrin-specific interfering RNA